Circulating fluid hypothermia method and apparatus

Information

  • Patent Grant
  • 6818011
  • Patent Number
    6,818,011
  • Date Filed
    Friday, February 16, 2001
    23 years ago
  • Date Issued
    Tuesday, November 16, 2004
    19 years ago
Abstract
A method and apparatus for performing hypothermia of a selected organ without significant effect on surrounding organs or other tissues. A flexible coaxial catheter is inserted through the vascular system of a patient to place the distal tip of the catheter in an artery feeding the selected organ. A chilled perfluorocarbon fluid is pumped through an insulated inner supply conduit of the catheter to cool a flexible bellows shaped heat transfer element in the distal tip of the catheter. The heat transfer bellows cools the blood flowing through the artery, to cool the selected organ, distal to the tip of the catheter.
Description




STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT




Not Applicable




BACKGROUND OF THE INVENTION




1. Field of the Invention




The current invention relates to selective cooling, or hypothermia, of an organ, such as the brain, by cooling the blood flowing into the organ. This cooling can protect the tissue from injury caused by anoxia or trauma.




2. Background Information




Organs of the human body, such as the brain, kidney, and heart, are maintained at a constant temperature of approximately 37° C. Cooling of organs below 35° C. is known to provide cellular protection from anoxic damage caused by a disruption of blood supply, or by trauma. Cooling can also reduce swelling associated with these injuries.




Hypothermia is currently utilized in medicine and is sometimes performed to protect the brain from injury. Cooling of the brain is generally accomplished through whole body cooling to create a condition of total body hypothermia in the range of 20° to 30° C. This cooling is accomplished by immersing the patient in ice, by using cooling blankets, or by cooling the blood flowing externally through a cardiopulmonary bypass machine. U.S. Pat. No. 3,425,419 to Dato and U.S. Pat. No. 5,486,208 to Ginsburg disclose catheters for cooling the blood to create total body hypothermia.




Total body hypothermia to provide organ protection has a number of drawbacks. First, it creates cardiovascular problems, such as cardiac arrhythmias, reduced cardiac output, and increased systemic vascular resistance. These side effects can result in organ damage. These side effects are believed to be caused reflexively in response to the reduction in core body temperature. Second, total body hypothermia is difficult to administer. Immersing a patient in ice water clearly has its associated problems. Placement on cardiopulmonary bypass requires surgical intervention and specialists to operate the machine, and it is associated with a number of complications including bleeding and volume overload. Third, the time required to reduce the body temperature and the organ temperature is prolonged. Minimizing the time between injury and the onset of cooling has been shown to produce better clinical outcomes.




Some physicians have immersed the patient's head in ice to provide brain cooling. There are also cooling helmets, or head gear, to perform the same. This approach suffers from the problems of slow cool down and poor temperature control due to the temperature gradient that must be established externally to internally. It has also been shown that complications associated with total body cooling, such as arrhythmia and decreased cardiac output, can also be caused by cooling of the face and head only.




Selective organ hypothermia has been studied by Schwartz, et. al. Utilizing baboons, blood was circulated and cooled externally from the body via the femoral artery and returned to the body through the carotid artery. This study showed that the brain could be selectively cooled to temperatures of 20° C. without reducing the temperature of the entire body. Subsequently, cardiovascular complications associated with total body hypothermia did not occur. However, external circulation of the blood for cooling has not yet been a widely accepted approach for the treatment of humans. The risks of infection, bleeding, and fluid imbalance are great. Also, at least two arterial vessels must be punctured and cannulated. Further, percutaneous cannulation of the carotid artery is very difficult and potentially fatal, due to the associated arterial wall trauma. Also, this method could not be used to cool organs such as the kidneys, where the renal arteries cannot be directly cannulated percutaneously.




Selective organ hypothermia has also been attempted by perfusing the organ with a cold solution, such as saline or perflourocarbons. This is commonly done to protect the heart during heart surgery and is referred to as cardioplegia. This procedure has a number of drawbacks, including limited time of administration due to excessive volume accumulation, cost and inconvenience of maintaining the perfusate, and lack of effectiveness due to temperature dilution from the blood. Temperature dilution by the blood is a particular problem in high blood flow organs such as the brain. For cardioplegia, the blood flow to the heart is minimized, and therefore this effect is minimized.




Intravascular, selective organ hypothermia, created by cooling the blood flowing into the organ, is the ideal method. First, because only the target organ is cooled, complications associated with total body hypothermia are avoided. Second, because the blood is cooled intravascularly, or in situ, problems associated with external circulation of blood are eliminated. Third, only a single puncture and arterial vessel cannulation is required, and it can be performed at an easily accessible artery such as the femoral, subclavian, or brachial. Fourth, cold perfusate solutions are not required, thus eliminating problems with excessive fluid accumulation. This also eliminates the time, cost, and handling issues associated with providing and maintaining cold perfusate solution. Fifth, rapid cooling can be achieved. Sixth, precise temperature control is possible.




Previous inventors have disclosed the circulation of cold water or saline solution through an uninsulated catheter in a major vessel of the body to produce total body hypothermia. This approach has not been successful at selective organ hypothermia, for reasons demonstrated below.




The important factor related to catheter development for selective organ hypothermia is the small size of the typical feeding artery, and the need to prevent a significant reduction in blood flow when the catheter is placed in the artery. A significant reduction in blood flow would result in ischemic organ damage. While the diameter of the major vessels of the body, such as the vena cava and aorta, are as large as 15 to 20 mm., the diameter of the feeding artery of an organ is typically only 4.0 to 8.0 mm. Thus, a catheter residing in one of these arteries cannot be much larger than 2.0 to 3.0 mm. in outside diameter. It is not practical to construct a selective organ hypothermia catheter of this small size using the circulation of cold water or saline solution. Using the brain as an example, this point will be illustrated.




The brain typically has a blood flow rate of approximately 500 to 750 cc/min. Two carotid arteries feed this blood supply to the brain. The internal carotid is a small diameter artery that branches off of the common carotid near the angle of the jaw. To cool the brain, it is important to place some of the cooling portion of the catheter into the internal carotid artery, so as to minimize cooling of the face via the external carotid, since face cooling can result in complications, as discussed above. It would be desirable to cool the blood in this artery down to 32° C., to achieve the desired cooling of the brain. To cool the blood in this artery by a 5° C. drop, from 37° C. down to 32° C., requires between 100 and 150 watts of refrigeration power.




In order to reach the internal carotid artery from a femoral insertion point, an overall catheter length of approximately 100 cm. would be required. To avoid undue blockage of the blood flow, the outside diameter of the catheter can not exceed approximately 2 mm. Assuming a coaxial construction, this limitation in diameter would dictate an internal supply tube of about 0.70 mm. diameter, with return flow being between the internal tube and the external tube.




A catheter based on the circulation of fluid operates on the principle of transferring heat from the blood to raise the temperature of the water. The fluid must warm up to absorb heat and produce cooling. Water flowing at the rate of 5.0 grams/sec, at an initial temperature of 0° C. and warming up to 5° C., can absorb 100 watts of heat. Thus, the outer surface of the heat transfer element could only be maintained at 5° C., instead of 0° C. This will require the heat transfer element to have a surface area of approximately 1225 mm


2


. If a catheter of approximately 2.0 mm. diameter is assumed, the length of the heat transfer element would have to be approximately 20 cm.




In actuality, if circulated through an uninsulated catheter, the water or saline solution would undoubtedly warm up before it reached the heat transfer element, and provision of 0° C. water at the heat transfer element would be impossible. Circulating a cold liquid through an uninsulated catheter also would cause cooling along the catheter body and could result in non-specific or total body hypothermia. Furthermore, to achieve this heat transfer rate, 5 grams/sec of water flow are required. To circulate water through a 100 cm. long, 0.70 mm. diameter supply tube at this rate produces a pressure drop of more than 3000 psi. This pressure exceeds the safety levels of many flexible medical grade plastic catheters. Further, it is doubtful whether a water pump that can generate these pressures and flow rates can be placed in an operating room.




BRIEF SUMMARY OF THE INVENTION




The selective organ cooling achieved by the present invention is accomplished by placing a coaxial cooling catheter into the feeding artery of the organ. Cold perfluorocarbon fluid is circulated through the catheter. In the catheter, a shaft or body section would carry the perfluorocarbon fluid to a distal flexible heat transfer element where cooling would occur. A preferred heat transfer element would be bellows shaped. Cooling of the catheter tip to temperatures above minus 2° C. results in cooling of the blood flowing into the organ located distally of the catheter tip, and subsequent cooling of the target organ. For example, the catheter could be placed into the internal carotid artery, to cool the brain. The size and location of this artery places significant demands on the size and flexibility of the catheter. Specifically, the outside diameter of the catheter must be minimized, so that the catheter can fit into the artery without compromising blood flow. An appropriate catheter for this application would have a flexible body of 70 to 100 cm. in length and 2.0 to 3.0 mm. in outside diameter.




It is important for the catheter to be flexible in order to successfully navigate the arterial path, and this is especially true of the distal end of the catheter. So, the distal end of the catheter must have a flexible heat transfer element, which is composed of a material which conducts heat better than the remainder of the catheter. The catheter body material could be nylon or PBAX, and the heat transfer element could be made from a material having higher thermal conductivity, such as nitinol, nickel, copper, silver, or gold. Ideally, the heat transfer element is formed with a maximized or convoluted surface area, such as a bellows. A bellows has a convoluted surface, with fin-like annular folds, causing the bellows to be very flexible, even though the bellows is constructed of a metallic material. Further, the convoluted surface of the bellows causes it to have a much larger surface area than a straight tube of the same length. Still further, the bellows is axially compressible, making it ideal for use on the tip of a catheter which will be navigated through the vascular system of a patient. If the bellows abuts the wall of an artery, the bellows will easily compress, thereby eliminating or reducing the trauma to the arterial wall.




Bellows can be formed with known techniques to be seamless and non-porous, therefore being impermeable to gas. Metallic bellows in the sizes appropriate for use in the present invention are known, which have helium leak rates less than 10


−6


cc/sec. Impermeability and low leakage are particularly important for use in the present invention, where refrigerant gas will be circulated through the vascular system of a patient.




Bellows are also mechanically robust, being capable of withstanding more than 10,000 cycles of axial loading and unloading. Further, metallic bellows are known to tolerate the cryogenic temperatures generated in the device of the present invention, without loss of performance. Finally, metallic bellows can be made in large quantities, relatively inexpensively, making them ideal for use in disposable medical device.




Because the catheter body and heat transfer element of the present invention may dwell in the vascular system of the patient for extended periods, up to 48 hours in some cases, they might be susceptible to blood clot formation if no preventive measures are taken. This is particularly true of the bellows design, because some blood stasis may occur in the annular folds of the bellows, allowing clot forming agents to cling to the bellows surface and form a thrombus. Therefore, treatment of the catheter body and bellows surfaces to prevent clot formation is desirable. One such treatment is the binding of antithrombogenic agents, such as heparin, to the surface. Another such treatment is the bombardment of the surface with ions, such as nitrogen ions, to harden and smooth the surface, thereby preventing clot forming agents from clinging to the surface.




The heat transfer element would require sufficient surface area to absorb 100 to 150 watts of heat, in the carotid artery example. This could be accomplished with a bellows element of approximately 2 mm. diameter, 13 cm. in length, with a surface temperature of 0° C. The cooling would be provided by the circulation of a perfluorocarbon fluid through an inner supply tube, returning through the annular space between the inner supply tube and the outer tubular catheter body. The inner tube has insulating means, such as longitudinal channels. The longitudinal channels can be filled with a gas, or evacuated. Further, the outer tube of the catheter body can have insulating means, such as longitudinal channels, which also can be filled with a gas or evacuated.




For example, a perfluorocarbon fluid flowing at a flow rate of between two (2) and three (3) grams/sec could provide between approximately 100 and 150 watts of refrigeration power. Utilizing an insulated catheter allows the cooling to be focused at the heat transfer element, thereby eliminating cooling along the catheter body. Utilizing perfluorocarbon fluid also lowers the fluid flow rate requirement, as compared to water or saline solution, to remove the necessary amount of heat from the blood. This is important because the required small diameter of the catheter would have higher pressure drops at higher flow rates.




The catheter would be built in a coaxial construction with a 1.25 mm. inner supply tube diameter and a 2.5 mm. outer return tube diameter. This results in tolerable pressure drops of the fluid along the catheter length, as well as minimizing the catheter size to facilitate carotid placement. The inner tube would carry the perfluorocarbon fluid to the heat transfer bellows element at the distal end of the catheter body. If a bellows surface temperature of 0° C. is maintained, just above the freezing point of blood, then 940 mm


2


of surface area in contact with the blood are required to lower the temperature of the blood by the specified 5° C. drop. This translates to a 2.0 mm. diameter heat transfer bellows by 13 cm. in length. To generate 0° C. on the bellows surface, the perfluorocarbon fluid must be supplied at a temperature of minus 50° C.




It is important to use a perfluorocarbon fluid, for several reasons. First, these compounds have very low viscosities, even at low temperatures. Therefore, they can be circulated through small tubing at high flow rates, with much less pressure drop than water or saline solution. Second, they can be cooled below 0° C. without freezing, allowing colder fluid to be delivered to the heat transfer element. Since more heat can be transferred to the lower temperature heat transfer element, lower flow rates are required to achieve the same cooling capacity as higher flow rates of water or saline. This further decreases the pressure drop experienced in the tubing. Since some warming is likely to occur along the catheter body, it is also helpful to use a fluid which can be cooled to a lower temperature, thereby delivering the desired cooling capacity at the distal tip of the catheter.




Third, perfluorocarbon fluids have very low surface tension, as compared to water or saline solution. This is important in applications where the heat transfer element has highly convoluted surface contours to maximize surface area, such as the bellows heat transfer element. A fluid with low surface tension will wet the internal surface of such a heat transfer element, resulting in increased heat transfer, whereas a fluid with a higher surface tension, such as water, which will not completely wet the surface. Fourth, perfluorocarbon fluids are inert and non-toxic compounds, even having been used as blood substitutes. This is an important safety concern, in the event of a leak. Finally, perfluorocarbon fluids are chemically compatible with many of the plastics which are used in making catheters. This is important, since catheter deterioration could be a serious problem in applications where the catheter may remain in the vascular system of the patient, circulating fluid, for long periods of time.




The novel features of this invention, as well as the invention itself, will be best understood from the attached drawings, taken along with the following description, in which similar reference characters refer to similar parts, and in which:











BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS





FIG. 1

is a schematic, partially in section, of the apparatus of the present invention, showing a first embodiment of the flexible catheter;





FIG. 2

is a perspective view of a second embodiment of the distal tip of the catheter;





FIG. 3

is a section view of a third embodiment of the distal tip of the catheter;





FIG. 4

is a partial section view of a fourth embodiment of the distal tip of the catheter;





FIG. 5

is an elevation view of a fifth embodiment of the distal tip of the catheter;





FIG. 6

is an elevation view of the embodiment shown in

FIG. 5

, after transformation to a double helix;





FIG. 7

is an elevation view of the embodiment shown in

FIG. 5

, after transformation to a looped coil;





FIG. 8

is an elevation view of a sixth embodiment of the distal tip of the catheter, showing longitudinal fins on the heat transfer element;





FIG. 9

is an end view of the embodiment shown in

FIG. 8

;





FIG. 10

is an elevation view of a seventh embodiment of the distal tip of the catheter, showing annular fins on the heat transfer element;





FIG. 11

is an end view of the embodiment shown in

FIG. 10

;





FIG. 12

is a longitudinal section of the distal tip of an eighth embodiment of the catheter of the present invention, showing a bellows heat transfer element; and





FIG. 13

is a transverse section of one embodiment of an insulated single wall tube for use in the present invention.











DETAILED DESCRIPTION OF THE INVENTION




As shown in

FIG. 1

, the apparatus includes a flexible coaxial catheter assembly


10


, fed by a pumping or circulating unit


12


, which can include a pump


13


and a chiller


15


, with a freon based refrigerant loop


17


. The circulating unit


12


has an outlet


14


and an inlet


16


. The catheter assembly


10


has an outer flexible catheter body


18


, which can be made of braided PBAX or other suitable catheter material. The catheter assembly


10


also has an inner flexible perfluorocarbon supply conduit


20


, which can be made of nylon, polyimide, PBAX, or other suitable catheter material. Both the catheter body


18


and the supply conduit


20


should be insulated, with a preferred means of insulation being discussed in more detail below.




The lumen


19


of the catheter body


18


serves as the return flow path for the circulating perfluorocarbon. The catheter body


18


and the supply conduit


20


must be flexible, to enable passage through the vascular system of the patient to the feeding artery of the selected organ. The length and diameter of the catheter body


18


and perfluorocarbon supply conduit


20


are designed for the size and location of the artery in which the apparatus will be used. For use in the internal carotid artery to achieve hypothermia of the brain, the catheter body


18


and perfluorocarbon supply conduit


20


will have a length of approximately 70 to 100 centimeters. The catheter body


18


for this application will have an outside diameter of approximately 2.5 millimeters and an inside diameter of approximately 2.0 millimeters, and the perfluorocarbon supply conduit


20


will have an outside diameter of approximately 1.25 millimeter and an inside diameter of approximately 1.0 millimeter. A supply conduit


20


and a return flow path through a catheter body


18


of these diameters will have a perfluorocarbon pressure drop of significantly less than the pressure drop that would be exhibited by water or a saline solution.




The circulating unit outlet


14


is attached in fluid flow communication, by known means, to a proximal end of the perfluorocarbon supply conduit


20


disposed coaxially within said catheter body


18


. The distal end of the perfluorocarbon supply conduit


20


has an outlet adjacent to or within a chamber of a flexible heat transfer element such as the hollow flexible tube


24


. The tube


24


shown in this embodiment is flexible but essentially straight in its unflexed state. The heat transfer element must be flexible, to enable passage through the vascular system of the patient to the feeding artery of the selected organ. For the internal carotid application the flexible tube


24


will have a length of approximately 15 centimeters, an outside diameter of approximately 1.9 millimeters and an inside diameter of approximately 1.5 millimeters. The heat transfer element also includes a plug


26


in the distal end of the flexible tube


24


. The plug


26


can be epoxy potting material, plastic, or a metal such as stainless steel or gold. A tapered transition of epoxy potting material can be provided between the catheter body


18


and the flexible tube


24


.




A perfluorocarbon, such as FC-77, made by Dupont, is chilled and pumped through the perfluorocarbon supply conduit


20


into the interior chamber of the heat transfer element, such as the flexible tube


24


, thereby cooling the heat transfer element


24


. Blood in the feeding artery flows around the heat transfer element


24


, thereby being cooled. The blood then continues to flow distally into the selected organ, thereby cooling the organ. FC-77 is a suitable perfluorocarbon, because it has a freezing point of −110° C., a viscosity of 0.8 centistokes at 25° C., and a surface tension of 15 dynes per centimeter. Other suitable perfluorocarbons include FC-72 and FC-75, also made by Dupont.




A second embodiment of the heat transfer element is shown in FIG.


2


. This embodiment can be constructed or a tubular material such as nitinol, which has a temperature dependent shape memory. The heat transfer element


28


can be originally shaped like the flexible tube


24


shown in

FIG. 1

, at room temperature, but trained to take on the coiled tubular shape shown in

FIG. 2

at a lower temperature. This allows easier insertion of the catheter assembly


10


through the vascular system of the patient, with the essentially straight but flexible tubular shape, similar to the flexible tube


24


. Then, when the heat transfer element is at the desired location in the feeding artery, such as the internal carotid artery, circulation of chilled perfluorocarbon is commenced. As the chilled perfluorocarbon cools the heat transfer element down, the heat transfer element takes on the shape of the heat transfer coil


28


shown in FIG.


2


. thereby creating a blood flow passageway through the heat transfer element. This enhances the heat transfer capacity, while limiting the length of the heat transfer element.




A third embodiment of the heat transfer element is shown in FIG.


3


. In this embodiment, the perflourocarbon supply conduit


20


has an outlet


30


in an interior chamber


32


at the distal end of the heat transfer element. The heat transfer element is a plurality of hollow tubes


34


leading from the interior chamber


32


of the heat transfer element to the perfluorocarbon return lumen


19


of the catheter body


18


. This embodiment of the heat transfer element


34


can be constructed of a tubular material such as nitinol, which has a temperature dependent shape memory, or some other tubular material having a permanent bias toward a curved shape. The heat transfer element tubes


34


can be essentially straight, originally, at room temperature, but trained to take on the outwardly flexed “basket”, or “oval” shape shown in

FIG. 3

at a lower temperature. This allows easier insertion of the catheter assembly


10


through the vascular system of the patient, with the essentially straight but flexible tubes. Then, when the heat transfer element


34


is at the desired location in the feeding artery, such as the internal carotid artery, refrigerant flow is commenced. As the expanding refrigerant cools the heat transfer element


34


down, the heat transfer element takes on the basket shape shown in FIG.


3


. This enhances the heat transfer capacity, while limiting the length of the heat transfer element.




A fourth embodiment of the heat transfer element is shown in FIG.


4


. This embodiment can be constructed of a material such as nitinol. The heat transfer element


36


can be originally shaped as a long loop connecting the distal end of the catheter body


18


to the distal end of the perfluorocarbon supply conduit


20


, at room temperature, but trained to take on the coiled tubular shape shown in

FIG. 4

at a lower temperature, with the heat transfer element


36


coiled around the perfluorocarbon supply conduit


20


. This allows easier insertion of the catheter assembly


10


through the vascular system of the patient, with the essentially straight but flexible tubular loop shape. Then, when the heat transfer element


36


is at the desired location in the feeding artery, such as the internal carotid artery, circulation of chilled perfluorocarbon is commenced. As the chilled perfluorocarbon cools the heat transfer element


36


down, the heat transfer element


36


takes on the shape of the coil shown in FIG.


4


. The convoluted surface of this coil enhances the heat transfer capacity, while limiting the length of the heat transfer element


36


.

FIG. 4

further illustrates that a thermocouple


38


can be incorporated into the catheter body


18


for temperature sensing purposes.




Yet a fifth embodiment of the heat transfer element is shown in

FIGS. 5

,


6


, and


7


. This embodiment of the heat transfer element can be constructed of a material such as nitinol. The heat transfer element is originally shaped as a long loop


40


extending from the distal ends of the catheter body


18


and the perfluorocarbon supply conduit


20


, at room temperature. The long loop


40


has two sides


42


,


44


, which are substantially straight but flexible at room temperature. The sides


42


.


44


of the long loop


40


can he trained to take on the double helical shape shown in

FIG. 6

at a lower temperature, with the two sides


42


,


44


of the heat transfer element


40


coiled around each other, the double helical shape of the loop having a blood flow passageway therethrough. Alternatively, the sides


42


,


44


of the long loop


40


can be trained to take on the looped coil shape shown in

FIG. 7

at a lower temperature with each of the two sides


42


,


44


of the heat transfer element


40


coiled independently. Either of these shapes allows easy insertion of the catheter assembly


10


through the vascular system of the patient, with the essentially straight but flexible tubular loop shape. Then, when the heat transfer element


40


is at the desired location in the feeding artery, such as the internal carotid artery, circulation of chilled perfluorocarbon is commenced. As the chilled perfluorocarbon cools the heat transfer element


40


down, the heat transfer element


40


takes on the double helical shape shown in

FIG. 6

or the looped coil shape shown in FIG.


7


. Both of these configurations give the heal transfer element


40


a convoluted surface, thereby enhancing the heat transfer capacity, while limiting the length of the heat transfer element


40


.




As shown in

FIGS. 8 through 11

, the tubular heat transfer element


24


can have external fins


46


,


48


attached thereto, such as by welding or brazing, to give the heat transfer element


24


a convoluted surface, thereby promoting heat transfer. Use of a convoluted surface, such as fins, allows the use of a shorter heat transfer element without reducing the heat transfer surface area, or increases the heat transfer surface area for a given length. In

FIGS. 8 and 9

, a plurality of longitudinal fins


46


are attached to the heat transfer element


24


. The heat transfer element


24


in such an embodiment can have a diameter of approximately 1.0 millimeter, while each of the fins


46


can have a width of approximately 0.5 millimeter and a thickness of approximately 0.12 millimeter. This will give the heat transfer element an overall diameter of approximately 2.0 millimeters, still allowing the catheter to be inserted into the internal carotid artery.




In

FIGS. 10 and 11

, a plurality of annular fins


48


are attached to the heat transfer element


24


. The heat transfer element


24


in such an embodiment can have a diameter of approximately 1.0 millimeter, while each of the fins


48


can have a width of approximately 0.5 millimeter and a thickness of approximately 0.12 millimeter. This will give the heat transfer element an overall diameter of approximately 2.0 millimeters, still allowing the catheter to be inserted into the internal carotid artery.




As shown in

FIG. 12

, the present invention can include a bellows shaped heat transfer element


23


on the distal end of the catheter body


18


. The heat transfer bellows


23


can be constructed of a metal having a high thermal conductivity, such as nitinol, nickel, copper, silver, gold, or some other suitable material. The catheter body


18


of braided PBAX can have a distal section


21


of non-braided PBAX. The heat transfer bellows


23


comprises a tubular throat


25


fitted within the distal section


21


of the catheter. A plurality of annular folds


27


extend from the distal end of the throat


25


. An end cap


29


is formed at the distal end of the annular folds


27


.




The distal section


21


of non-braided PBAX can be melted or shrunk onto the bellows throat


25


. A shrink fit tube


31


of a suitable plastic can be formed onto the distal section


21


of the catheter and the bellows throat


25


, to form a smooth transition. To prevent thrombosis, an antithrombogenic agent such as heparin can be bonded to the outer surface


33


of the bellows


23


, particularly on the annular folds


27


. Alternatively, the outer surface


33


of the bellows


23


can be nitrided or subjected to a similar treatment to create a smooth surface which retards thrombosis.




The inner perfluorocarbon supply conduit


20


should be insulated to prevent warming of the cold supply perfluorocarbon by the warmer return perfluorocarbon in the outer lumen


19


. In one embodiment, a single wall perfluorocarbon supply conduit


20


could be constructed with a ring of parallel longitudinal lumens in the wall of the conduit


20


, surrounding the cold perfluorocarbon flow path. These parallel longitudinal lumens could be evacuated, actively or passively, or filled with insulating material. Similarly, the outer lumen


19


of the catheter body


18


, which carries the return perfluorocarbon flow, could be insulated, to reduce the warming of the return flow by the blood surrounding the catheter body


18


.

FIG. 13

is a transverse section of an insulated single wall tube which could be used for either the insulated catheter body


18


or the supply conduit


20


, or both. The catheter body


18


or supply conduit


20


has a single wall


50


, with an inner lumen


52


for flow of the perfluorocarbon. A plurality of longitudinal insulating lumens


54


are arranged surrounding, and parallel to, the inner lumen


52


. Each insulating lumen


54


can be evacuated during manufacture of the circulating catheter assembly


10


. If evacuated during manufacture, each of the insulating lumens


54


could be sealed at its proximal end, creating a constant, passive vacuum in each of the insulating lumens


54


. Alternatively, the insulating lumens


54


could be evacuated during use of the circulating catheter assembly


10


, such as by the use of a vacuum pump or syringe (not shown). Conversely, the insulating lumens


54


could be filled with an insulating material. As mentioned above, this insulated single wall design could be used for the supply conduit


20


, or the catheter body


18


, or both.




While the particular invention as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages hereinbefore stated, it is to be understood that this disclosure is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended other than as described in the appended claims.



Claims
  • 1. A cooling apparatus, comprising:a circulating unit adapted for chilling and circulating a fluid; a flexible elongated catheter; a flexible tubular outer catheter body on said catheter; a flexible, insulated, supply tube within said outer catheter body, a proximal end of a central lumen of said supply tube being connected in fluid flow communication with an outlet of said circulating unit; a return lumen within said outer catheter body, said return lumen substantially surrounding said fluid supply tube, a proximal end of said return lumen being connected in fluid flow communication with an inlet of said circulating unit; and a flexible heat transfer element mounted to a distal end of said outer catheter body, said heat transfer element having a partially helical shape to increase the surface area available for heat transfer and a blood flow passageway through the partially helical shape of the heat transfer element; wherein said fluid supply tube comprises a wall having insulating properties to reduce heat transfer from said return lumen to said central lumen of said fluid supply tube.
CROSS REFERENCE TO RELATED APPLICATIONS

This is a continuation patent application of U.S. patent application Ser. No. 09/052,545 filed on Mar. 31, 1998 now U.S. Pat. No. 6,231,595, entitled “Circulating Fluid Hypothermia Method and Apparatus”.

US Referenced Citations (146)
Number Name Date Kind
2308484 Auzin et al. Jan 1943 A
2374609 McCollum Apr 1945 A
2615686 Davidson Oct 1952 A
2672032 Towse Mar 1954 A
2913009 Kuthe Nov 1959 A
3125096 Antiles et al. Mar 1964 A
3298371 Lee Jan 1967 A
3425419 Dato Feb 1969 A
3504674 Swenson et al. Apr 1970 A
3865116 Brooks Feb 1975 A
3888259 Miley Jun 1975 A
3971383 Van Gerven Jul 1976 A
4038519 Foucras Jul 1977 A
4153048 Magrini May 1979 A
4190033 Foti Feb 1980 A
4231425 Engstrom Nov 1980 A
4275734 Mitchiner Jun 1981 A
4298006 Parks Nov 1981 A
4318722 Altman Mar 1982 A
4427009 Wells et al. Jan 1984 A
4445500 Osterholm May 1984 A
4483341 Witteles Nov 1984 A
4502286 Okada et al. Mar 1985 A
4569355 Bitterly Feb 1986 A
4581017 Sahota Apr 1986 A
4655746 Daniels et al. Apr 1987 A
4672962 Hershenson Jun 1987 A
4748979 Hershenson Jun 1988 A
4750493 Brader Jun 1988 A
4762129 Bonzel Aug 1988 A
4762130 Fogarty et al. Aug 1988 A
4781799 Herbert, Jr. et al. Nov 1988 A
4820349 Saab Apr 1989 A
4860744 Johnson et al. Aug 1989 A
4883455 Leonard Nov 1989 A
4894164 Polaschegg Jan 1990 A
4904237 Janese Feb 1990 A
4920963 Brader May 1990 A
4964409 Tremulis Oct 1990 A
5002531 Bonzel Mar 1991 A
5014695 Benak et al. May 1991 A
5018521 Campbell May 1991 A
5019075 Spears et al. May 1991 A
5041089 Mueller et al. Aug 1991 A
5078713 Varney Jan 1992 A
5092841 Spears Mar 1992 A
5106360 Ishiwara et al. Apr 1992 A
5108390 Potocky et al. Apr 1992 A
5110721 Anaise et al. May 1992 A
5112438 Bowers May 1992 A
5117822 Laghi Jun 1992 A
5147355 Friedman et al. Sep 1992 A
5149321 Klatz et al. Sep 1992 A
5150706 Cox et al. Sep 1992 A
5151100 Abele et al. Sep 1992 A
5180364 Ginsburg Jan 1993 A
5190539 Fletcher et al. Mar 1993 A
5191883 Lennox et al. Mar 1993 A
5196024 Barath Mar 1993 A
5211631 Sheaff May 1993 A
5234405 Klatz et al. Aug 1993 A
5248312 Langberg Sep 1993 A
5250070 Parodi Oct 1993 A
5257977 Eshel Nov 1993 A
5264260 Saab Nov 1993 A
5269369 Faghri Dec 1993 A
5269749 Koturov Dec 1993 A
5269758 Taheri Dec 1993 A
5281213 Milder et al. Jan 1994 A
5281215 Milder Jan 1994 A
5306261 Alliger et al. Apr 1994 A
5310440 Zingher May 1994 A
5334193 Nardella Aug 1994 A
5340290 Clemens Aug 1994 A
5342181 Schock et al. Aug 1994 A
5342301 Saab Aug 1994 A
5344436 Fontenot et al. Sep 1994 A
5354186 Murtuza et al. Oct 1994 A
5365750 Greenthal Nov 1994 A
5368591 Lennox et al. Nov 1994 A
5383918 Panetta Jan 1995 A
5395314 Klatz et al. Mar 1995 A
5395331 O'Neill et al. Mar 1995 A
5403281 O'Neill et al. Apr 1995 A
5417686 Peterson et al. May 1995 A
5423745 Todd et al. Jun 1995 A
5423807 Milder Jun 1995 A
5433740 Yamaguchi Jul 1995 A
5437673 Baust et al. Aug 1995 A
5443456 Alliger et al. Aug 1995 A
5462521 Brucker et al. Oct 1995 A
5486204 Clifton Jan 1996 A
5486208 Ginsburg Jan 1996 A
5531776 Ward et al. Jul 1996 A
5558644 Boyd et al. Sep 1996 A
5573532 Chang et al. Nov 1996 A
5584804 Klatz et al. Dec 1996 A
5588438 McKown et al. Dec 1996 A
5591162 Fletcher et al. Jan 1997 A
5620480 Rudie Apr 1997 A
5624392 Saab Apr 1997 A
5643197 Brucker et al. Jul 1997 A
5647051 Neer Jul 1997 A
5713941 Robins et al. Feb 1998 A
5716386 Ward et al. Feb 1998 A
5735809 Gorsuch Apr 1998 A
5797878 Bleam Aug 1998 A
5800480 Augustine et al. Sep 1998 A
5800488 Crockett Sep 1998 A
5807391 Wijkamp Sep 1998 A
5824030 Yang et al. Oct 1998 A
5827222 Klatz et al. Oct 1998 A
5827237 Macoviak et al. Oct 1998 A
5833671 Macoviak et al. Nov 1998 A
5837003 Ginsburg Nov 1998 A
5868735 Lafontaine Feb 1999 A
5871526 Gibbs et al. Feb 1999 A
5873835 Hastings et al. Feb 1999 A
5879329 Ginsburg Mar 1999 A
5899899 Arless et al. May 1999 A
5902268 Saab May 1999 A
5913885 Klatz et al. Jun 1999 A
5913886 Soloman Jun 1999 A
5916242 Schwartz Jun 1999 A
5957963 Dobak, III Sep 1999 A
5964751 Amplatz et al. Oct 1999 A
5967976 Larsen et al. Oct 1999 A
5989238 Ginsburg Nov 1999 A
5992158 Goddard et al. Nov 1999 A
6007692 Herbert et al. Dec 1999 A
6019783 Philips et al. Feb 2000 A
6033383 Ginsburg Mar 2000 A
6042559 Dobak, III Mar 2000 A
6051019 Dobak, III Apr 2000 A
6096068 Dobak, III et al. Aug 2000 A
6110168 Ginsburg Aug 2000 A
6126684 Gobin et al. Oct 2000 A
6146411 Noda et al. Nov 2000 A
6146814 Millet Nov 2000 A
6149670 Worthen et al. Nov 2000 A
6149673 Ginsburg Nov 2000 A
6149676 Ginsburg Nov 2000 A
6149677 Dobak, III Nov 2000 A
6165207 Balding et al. Dec 2000 A
6182666 Dobak, III Feb 2001 B1
20010008975 Dobak, III et al. Jul 2001 A1
Foreign Referenced Citations (41)
Number Date Country
730835 Aug 1997 AU
739996 Aug 1999 AU
734506 Oct 1999 AU
0655225 May 1993 EP
0 664 990 Nov 1997 EP
2 447 406 Aug 1980 FR
806 029 Feb 1981 SU
WO 9105528 May 1991 WO
WO 9304727 Mar 1993 WO
WO 9501814 Jan 1995 WO
WO 9640347 Dec 1996 WO
WO 9701374 Jan 1997 WO
WO 9725011 Jul 1997 WO
WO 9826831 Jun 1998 WO
WO 9831312 Jul 1998 WO
WO 9937226 Jul 1999 WO
WO 9948449 Sep 1999 WO
WO 9966970 Dec 1999 WO
WO 9966971 Dec 1999 WO
WO 0009054 Feb 2000 WO
WO 0010494 Mar 2000 WO
WO 0038601 Jul 2000 WO
WO 0047145 Aug 2000 WO
WO 0048670 Aug 2000 WO
WO 0051534 Sep 2000 WO
WO 0053135 Sep 2000 WO
WO 0057823 Oct 2000 WO
WO 0062837 Oct 2000 WO
WO 0066053 Nov 2000 WO
WO 0072779 Dec 2000 WO
WO 0072787 Dec 2000 WO
WO 0103606 Jan 2001 WO
WO 0108580 Feb 2001 WO
WO 0110323 Feb 2001 WO
WO 0110365 Feb 2001 WO
WO 0112061 Feb 2001 WO
WO 0112122 Feb 2001 WO
WO 0113809 Mar 2001 WO
WO 0113837 Mar 2001 WO
WO 0117471 Mar 2001 WO
WO 0119447 Mar 2001 WO
Non-Patent Literature Citations (27)
Entry
Ambrus; The Biphasic Nature and Temperature Dependence of the Activation of Human Plasminogen by Urokinase; May 1979; pp. 339-347; Research Communications in Chemical Pathology and Pharmacology, vol. 24, No. 2.
Bigelo; Hypothermia, Its Possible Role in Cardiac Surgery; Nov. 1959; pp. 849-866; Annals of Surgery, vol. 132, No. 5.
Cheatle; Cryostripping the long and Short Saphenous Veins; Jan. 1993; one page; Br. J. Surg., vol. 80.
Dexter; Blood Warms as It Blows Retrograde from a Femoral Cannulation Site to the Carotid Artery During Cadiopulmonary Bypass; Nov. 1994; pp. 393-397; Perfusion, vol. 9, No. 6.
Gillinov; Superior Cerebral Protection with Profound Hypothermia During Circulatory Arrest; Nov. 1992; pp. 1432-1439; Ann. Thorac. Surg., vol. 55.
Higazi; The Effect of Ultrasonic Irradiation and Temperature on Fibrinolytic Activity in Vitro; Aug. 1992; p. 251-253; Thrombosis Research, vol. 69, No. 2.
Imamaki; Retrograde Cerebral Perfusion with Hypothermic Blood Provides Efficient Protection of the Brain; Jul. 1995; pp. 325-333; Journal of Cardiac Surgery, vol. 10, No. 4, Part 1.
Jolin; Management of a Giant Intracranial Aneurysm Using Surface-Heparinized Extracorporeal Circulation and Controlled Deep Hypothermic Low Flow Perfusion; Aug. 1992; pp. 756-760; Acta Anaesthesiologica Scandinavia.
Jos R.C. Jansen, Ph.D., et al. (1997) Near continuous cardiac output by thermodilution. Journal of Clinical Monitoring 13:233-239.
Kimoto; Open Heart Surgery under Direct Vision with the Aid of Brain-Cooling by Irrigation; Jul. 1955; pp. 592-603; Surgery, vol. 39, No. 4.
Marekovic, Z.; Abstract of Renal Hypothermia in Situ by Venous Passages: Experimental Work on Dogs; 1980; Eur Urol 6(2); 1 page.
Meden; Effect of Hypothermia and Delayed Thrombolysis in a Rat Embolic Stroke Model; Dec. 1993; pp. 91-98; Acta Neurologica Scandinavica.
Meden; The Influence of Body Temperature on Infarct Volume and Thrombolytic in a Rat Embolic Stroke Model; Feb. 1994; pp. 131-138; Brain Research, vol. 647.
Milleret, Rene; La cryo-chirurgie danes les varices des mimbres inferieurs; Angiologie; Supplement au No. 110.
Milleret; Abstract of Cryosclerosis of the Saphenous Veins in Varicose Reflux in the Obese and Elderly; 10.1981; one page; Phlebologie, vol. 34, No. 4.
Parkins; Brain Cooling in the Prevention of Brain Damage During Periods of Circulatory Occlusion in Dogs; Apr. 1954; pp. 284-289; Annals of Surgery, vol. 140, No. 3.
Piepgras; Rapid Active Internal Core Cooling for Induction of Moderate Hypothermia in Head Injury by Use of an Extracorporeal Heat Exchanger, Feb. 1998; pp. 311-318, Neurosurgery, vol. 42, No. 2.
Rijken; Plasminogen Activation at Low Temperatures in Plasma Samples Containing Therapeutic Concentrations of Tissue-Type Plasminogen Activator or Other Thrombolytic Agents; Oct. 1989; pp. 47-52; place of publication unknown.
Schwartz, A.E. et al.; (1996); Isolated cerebral hypothermia by single carotid artery perfusion of extracorporeally cooled blood in baboons; Neurosurgery 39(3):577-582.
Schwartz; Cerebral Blood Flow during Low-flow Hypothermic Cardiopulmonay Bypass in Baboons; Jun. 1994; pp. 959-964; Anesthesiology, vol. 81, No. 4.
Schwartz; Selective Cerebral Hypothermia by Means of Transfemoral Internal Carotid Artery Catheterization; May 1996; pp. 571-572; Radiology, vol. 201, No. 2.
Steen; The Detrimental Effects of Prolonged Hypothermia and Rewarming in the Dog; Aug. 1979 ;pp. 224-230; Anesthesiology, vol. 52, No. 3.
Vandam; Hypothermia; Sep. 1959; pp. 546-553; The New England Journal of Medicine.
White; Cerebral Hypothermia and Circulatory Arrest; Jul. 1978; pp. 450-458; Mayo Clinic Proceedings, vol. 53.
Yenari; Thrombolysis with Tissue Plasminogen Activator (TPA) is Temperature Dependent; Jul. 1994; pp. 475-481; Thrombosis Research, vol. 77, No. 5.
Yoshihara; Changes in Coagulation and Fibrinolysis Occurring in Dogs during Hypothermia; Aug. 1984; pp. 503-512; Thrombosis Research, vol. 37, No. 4.
Zarins; Circulation in Profound Hypothermia; Nov. 1972; pp. 97-104; Journal of Surgical Research, vol. 14, N. 2.
Continuations (1)
Number Date Country
Parent 09/052545 Mar 1998 US
Child 09/785243 US